VEGFA and neoplasm: Because of the importance of anti-VEGF antibodies in the vaccine’s potential anti-tumor effects, the present paper is mainly devoted to the description and discussion of the humoral response results of the trial, and of those obtained during the follow up of surviving patients that continued to be vaccinated off-trial.